GLS1 loss in TNBC cell lines leads to dysregulated glutaminolysis, impairing tumor growth in vitro and in vivo, whereas GLS silencing has minimal effects on metabolic phenotype or growth in luminal cell lines. The gene discussed is GLS; the disease is neoplasm.